Heterogeneity in statin responses explained by variation in the human gut microbiome
Prior work has indicated that stain therapy impacts gut microbiome composition and that gut bacteria can metabolize statins, but the clinical implications of these interactions remain unknown. Wilmanski et al. identify robust associations between microbiome composition and on-target and adverse responses to statins, which could prove useful in drug personalization.
Read the full article: "Heterogeneity in statin responses explained by variation in the human gut microbiome” by Dr Wilmanski and colleagues: https://www.cell.com/med/fulltext/S26...
Video: Tomasz Wilmanski, PhD
Institute for Systems Biology, Seattle, WA, USA
Watch video Heterogeneity in statin responses explained by variation in the human gut microbiome online, duration hours minute second in high quality that is uploaded to the channel Cell Press 27 May 2022. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 423 times and liked it 9 visitors.
